AMPHOTERICIN B
Generic: AMPHOTERICIN B
XGen Pharmaceuticals DJBManufacturer
INTRAVENOUSRoute
AMPHOTERICIN BActive Substance
1992-04-29Original Approval
AMPHOTERICIN B is FDA application ANDA063206, sponsored by XGEN PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
DRUG INEFFECTIVE
4,204 reports
2
OFF LABEL USE
1,800 reports
3
CONDITION AGGRAVATED
839 reports
4
PYREXIA
824 reports
5
PRODUCT USE IN UNAPPROVED INDICATION
556 reports
6
ACUTE KIDNEY INJURY
553 reports
7
MULTIPLE ORGAN DYSFUNCTION SYNDROME
549 reports
8
SEPSIS
488 reports
9
FEBRILE NEUTROPENIA
483 reports
10
NEUTROPENIA
456 reports